Cancer drug patent case takes new turn

Posted on June 23rd, 2007 by admin

Times of India, June 19, 2007 The much-awaited appeal proceedings in a cancer drug patent case could not begin on Monday as Swiss major Novartis AG, turning the tables on the government, raised a conflict-of-interest objection to the composition of the two-member bench of the Intellectual Property Appellate Board (IPAB). How can an officer who [...]

No Comments »
Filed under: News, Patent Litigation, TRIPS

Novartis may suffer jolt in Glivec case

Posted on June 21st, 2007 by admin

Financial Express, June 20, 2007 The Intellectual Property Appellate Board (IPAB), which has been formed to give a verdict on various patent cases across the country, may reject Novartis objection on the presence of S Chandrasekharan, the former patent controller, on IPAB. Novartis had objected to Chandrasekharans presence on the board saying he was responsible [...]

No Comments »
Filed under: Article, News, Patent Litigation, TRIPS

If Novartis wins, other MNCs would also claim patents for well-known medicines

Posted on June 19th, 2007 by admin

The case filed by the big pharmaceutical company Novartis has attracted global attention. “Doctors Without Borders” winner of the Nobel Prize for best medical relief in 1999, has requested people all over the world to write to the company to drop the case. Over two lakh people have written to Novartis. Why is this case [...]

No Comments »
Filed under: Article, Campaign

  • Boycott Novartis is a campaign undertaken by the DRUG ACTION FORUM, India against Novartis, a pharmaceutical company dedicated to establishing a patent protected market in India, by the removal of barriers to competition. We are against Novartis patents, one pertaining specifically to access to treatment for thousands of patients suffering from Chronic Myeloid Leukemia (CML) and the other to a broader issue of the cost of new medicines that may be provided Patent protection.

  • Boycott Novartis
    ↑ Subscribe to this feed